File Download
Links for fulltext
(May Require Subscription)
- Find via
Supplementary
-
Citations:
- Appears in Collections:
Conference Paper: Oral arsenic trioxide in the treatment of relapsed acute promyelocytic leukaemia
| Title | Oral arsenic trioxide in the treatment of relapsed acute promyelocytic leukaemia |
|---|---|
| Authors | |
| Keywords | Medical sciences |
| Issue Date | 2003 |
| Publisher | Hong Kong Medical Association. The Journal's web site is located at http://www.hkmj.org.hk |
| Citation | The 8th Medical Research Conference (MRC 2003), Hong Kong, China, 25-26 January 2003. In Hong Kong Medical Journal, 2003, v. 9 suppl. 1, p. 59, abstract no. HO-06 How to Cite? |
| Abstract | INTRODUTION: Arsenic trioxide (As2O3) induces a remission in over 90% of patients with relapsed acute promyelocytic leukaemia (APL). To date, only the intravenous (i.v.) preparation of As2O3 has been used. We have recently developed an oral preparation of As2O3 that achieves blood levels of elemental arsenic comparable with those of i.v. As2O3 (Eur J Clin Pharmacol Oct 11, 2002 online). In this study, the efficacy and safety of oral As2O3 were … |
| Persistent Identifier | http://hdl.handle.net/10722/46908 |
| ISSN | 2021 Impact Factor: 1.256 2020 SCImago Journal Rankings: 0.357 |
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Au, WY | en_HK |
| dc.contributor.author | Kumana, CR | en_HK |
| dc.contributor.author | Kou, M | en_HK |
| dc.contributor.author | Mak, R | en_HK |
| dc.contributor.author | Chan, GCF | en_HK |
| dc.contributor.author | Lam, CW | en_HK |
| dc.contributor.author | Kwong, YL | en_HK |
| dc.date.accessioned | 2007-10-30T07:01:02Z | - |
| dc.date.available | 2007-10-30T07:01:02Z | - |
| dc.date.issued | 2003 | en_HK |
| dc.identifier.citation | The 8th Medical Research Conference (MRC 2003), Hong Kong, China, 25-26 January 2003. In Hong Kong Medical Journal, 2003, v. 9 suppl. 1, p. 59, abstract no. HO-06 | en_HK |
| dc.identifier.issn | 1024-2708 | en_HK |
| dc.identifier.uri | http://hdl.handle.net/10722/46908 | - |
| dc.description.abstract | INTRODUTION: Arsenic trioxide (As2O3) induces a remission in over 90% of patients with relapsed acute promyelocytic leukaemia (APL). To date, only the intravenous (i.v.) preparation of As2O3 has been used. We have recently developed an oral preparation of As2O3 that achieves blood levels of elemental arsenic comparable with those of i.v. As2O3 (Eur J Clin Pharmacol Oct 11, 2002 online). In this study, the efficacy and safety of oral As2O3 were … | - |
| dc.language | eng | en_HK |
| dc.publisher | Hong Kong Medical Association. The Journal's web site is located at http://www.hkmj.org.hk | en_HK |
| dc.relation.ispartof | Hong Kong Medical Journal | - |
| dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | - |
| dc.subject | Medical sciences | en_HK |
| dc.title | Oral arsenic trioxide in the treatment of relapsed acute promyelocytic leukaemia | en_HK |
| dc.type | Conference_Paper | en_HK |
| dc.identifier.openurl | http://library.hku.hk:4550/resserv?sid=HKU:IR&issn=1024-2708&volume=9&issue=1 Supp 1&spage=24&epage=&date=2003&atitle=Oral+arsenic+trioxide+in+the+treatment+of+relapsed+acute+promyelocytic+leukaemia | en_HK |
| dc.description.nature | published_or_final_version | en_HK |
| dc.identifier.hkuros | 82848 | - |
| dc.identifier.volume | 9 | - |
| dc.identifier.issue | suppl. 1 | - |
| dc.identifier.spage | 59, abstract no. HO-06 | - |
| dc.identifier.epage | 59, abstract no. HO-06 | - |
| dc.identifier.issnl | 1024-2708 | - |